JPS6254405B2 - - Google Patents
Info
- Publication number
- JPS6254405B2 JPS6254405B2 JP57196842A JP19684282A JPS6254405B2 JP S6254405 B2 JPS6254405 B2 JP S6254405B2 JP 57196842 A JP57196842 A JP 57196842A JP 19684282 A JP19684282 A JP 19684282A JP S6254405 B2 JPS6254405 B2 JP S6254405B2
- Authority
- JP
- Japan
- Prior art keywords
- coli
- plasma
- purified plasma
- blood
- purified
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 241000588724 Escherichia coli Species 0.000 claims description 27
- 210000004369 blood Anatomy 0.000 claims description 18
- 239000008280 blood Substances 0.000 claims description 18
- 230000001717 pathogenic effect Effects 0.000 claims description 11
- 230000000844 anti-bacterial effect Effects 0.000 claims description 8
- 241000283690 Bos taurus Species 0.000 claims description 7
- 241000282887 Suidae Species 0.000 claims description 7
- 108090000623 proteins and genes Proteins 0.000 claims description 7
- 102000004169 proteins and genes Human genes 0.000 claims description 7
- 239000012528 membrane Substances 0.000 claims description 5
- 150000003839 salts Chemical class 0.000 claims description 4
- 238000000108 ultra-filtration Methods 0.000 claims description 4
- 235000000346 sugar Nutrition 0.000 claims description 3
- 150000008163 sugars Chemical class 0.000 claims description 3
- 239000000047 product Substances 0.000 description 14
- 238000012360 testing method Methods 0.000 description 12
- 108010078777 Colistin Proteins 0.000 description 8
- 229960003346 colistin Drugs 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- JORAUNFTUVJTNG-BSTBCYLQSA-N n-[(2s)-4-amino-1-[[(2s,3r)-1-[[(2s)-4-amino-1-oxo-1-[[(3s,6s,9s,12s,15r,18s,21s)-6,9,18-tris(2-aminoethyl)-3-[(1r)-1-hydroxyethyl]-12,15-bis(2-methylpropyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptazacyclotricos-21-yl]amino]butan-2-yl]amino]-3-h Chemical compound CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H]([C@@H](C)O)CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O.CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@H]([C@@H](C)O)CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O JORAUNFTUVJTNG-BSTBCYLQSA-N 0.000 description 8
- XDJYMJULXQKGMM-UHFFFAOYSA-N polymyxin E1 Natural products CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(C(C)O)NC(=O)C(CCN)NC(=O)C(CCN)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCN)NC1=O XDJYMJULXQKGMM-UHFFFAOYSA-N 0.000 description 8
- KNIWPHSUTGNZST-UHFFFAOYSA-N polymyxin E2 Natural products CC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(C(C)O)NC(=O)C(CCN)NC(=O)C(CCN)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(CCN)NC1=O KNIWPHSUTGNZST-UHFFFAOYSA-N 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 7
- 206010012735 Diarrhoea Diseases 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 208000015181 infectious disease Diseases 0.000 description 5
- 235000013336 milk Nutrition 0.000 description 5
- 210000004080 milk Anatomy 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000008267 milk Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 230000004584 weight gain Effects 0.000 description 4
- 235000019786 weight gain Nutrition 0.000 description 4
- 230000003115 biocidal effect Effects 0.000 description 3
- 210000003022 colostrum Anatomy 0.000 description 3
- 235000021277 colostrum Nutrition 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- 230000002458 infectious effect Effects 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 102000009027 Albumins Human genes 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 2
- 108010044091 Globulins Proteins 0.000 description 2
- 102000006395 Globulins Human genes 0.000 description 2
- 230000004520 agglutination Effects 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 108010074605 gamma-Globulins Proteins 0.000 description 2
- 244000144972 livestock Species 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 206010048685 Oral infection Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000019784 crude fat Nutrition 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 231100000676 disease causative agent Toxicity 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 230000009422 growth inhibiting effect Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000008174 sterile solution Substances 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000012134 supernatant fraction Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Fodder In General (AREA)
- Dairy Products (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Feed For Specific Animals (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57196842A JPS5988042A (ja) | 1982-11-11 | 1982-11-11 | 精製血漿 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57196842A JPS5988042A (ja) | 1982-11-11 | 1982-11-11 | 精製血漿 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5988042A JPS5988042A (ja) | 1984-05-21 |
| JPS6254405B2 true JPS6254405B2 (enrdf_load_stackoverflow) | 1987-11-14 |
Family
ID=16364564
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP57196842A Granted JPS5988042A (ja) | 1982-11-11 | 1982-11-11 | 精製血漿 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5988042A (enrdf_load_stackoverflow) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01115774U (enrdf_load_stackoverflow) * | 1988-01-27 | 1989-08-03 |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0716366B2 (ja) * | 1986-05-26 | 1995-03-01 | 伊藤ハム株式会社 | 子豚用嗜好性改善飼料 |
| US5372811A (en) * | 1993-12-03 | 1994-12-13 | American Meat Protein Corporation | Animal feed supplement containing co-spray dried plasma protein and amylase |
| JP5380059B2 (ja) * | 2007-11-30 | 2014-01-08 | 日本ハム株式会社 | 豚下痢症改善剤及び豚用飼料 |
| JP5397990B2 (ja) * | 2009-03-12 | 2014-01-22 | 日本ハム株式会社 | 免疫賦活ペプチド及びそれを含む飼料 |
| CN111295094A (zh) | 2017-10-09 | 2020-06-16 | 泰尔茂比司特生物技术有限公司 | 冻干容器及使用冻干容器的方法 |
| WO2020185909A2 (en) | 2019-03-14 | 2020-09-17 | Terumo Bct Biotechnologies, Llc | Lyophilization loading tray assembly and system |
-
1982
- 1982-11-11 JP JP57196842A patent/JPS5988042A/ja active Granted
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01115774U (enrdf_load_stackoverflow) * | 1988-01-27 | 1989-08-03 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5988042A (ja) | 1984-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1340183C (en) | Immunologically active whey fraction and recovery process | |
| ES2236928T3 (es) | Suplemento proteinico de plasma granular con bioeficacia mejorada. | |
| US4816252A (en) | Product and process for transferring passive immunity to newborn domestic animals using ultrafiltered whey containing immunoglobulins | |
| US5066491A (en) | Method of disease treatment utilizing an immunologically active whey fraction | |
| US4096244A (en) | Immunoglobulins for administration to piglets | |
| US5645834A (en) | Method and product for treating failure of passive transfer and improving milk production in bovine species | |
| CA2013941A1 (en) | Process for preparing a therapeutic agent for rotavirus infection | |
| JPS6254405B2 (enrdf_load_stackoverflow) | ||
| US4141970A (en) | Method for enhancing the resistance of new born mammalian young to gastro-intestinal infections | |
| US5198213A (en) | Method of disease treatment utilizing an immunologically whey fraction | |
| Weström et al. | Protease inhibitor levels in porcine mammary secretions | |
| CN111068050A (zh) | 含猫泛白细胞减少症卵黄抗体的保护液的制备方法 | |
| Brown et al. | Lactoperoxidase, thiocyanate, and free cystine in bovine mammary secretions in early dry period and at the start of lactation and their effect on Streptococcus agalactiae growth | |
| US7547770B2 (en) | Colostral fractionation process | |
| Wright et al. | Purification of recombinant proteins from sheep's milk | |
| JPS6240251A (ja) | 子豚用飼料 | |
| JPS61132143A (ja) | グロブリン含有飼料 | |
| US20070212367A1 (en) | Novel immunologically active peptide fragments of a proline-rich polypeptide isolated from colostral mammalian fluids for treatment of viral and non-viral diseases or diseased conditions | |
| JPS60176550A (ja) | 血液の免疫蛋白含有飼料 | |
| RU2108794C1 (ru) | Способ получения иммуноглобулинового препарата | |
| JPH0349648A (ja) | 細菌毒素中和能を付与した育児用粉乳 | |
| JP2935193B2 (ja) | ロタウイルス感染症治療剤の製法 | |
| Erskine | A new laboratory method for preventing bacteriophage attack on cheese starter streptococci | |
| Vellenga et al. | Effects of irradiated sow colostrum on some biochemical and haematological measurements in newborn piglets | |
| JPS6236483B2 (enrdf_load_stackoverflow) |